Unveiling Current Insights on Acne Vulgaris and Rosacea

18 min

Speaker

Speaker profile

Nelva K. Jusuf

Indonesia

Year Education Program 1993 Medical Doctor, Faculty of Medicine Universitas Sumatera Utara 2001 Specialist of Dermatology Venereology and Aesthetic, Faculty of Medicine Universitas Sumatera Utara 2006 Advance Dermatology, National Skin Centre, Singapore 2008 Consultant of Cosmetic and Aesthetic Dermatology, Kolegium Dermatologi dan Venereologi (KDVI)/ Indonesian Collegium of Dermatology and Venereology 2012 Doctorate degree in Medical Sciences, Faculty of Medicine Universitas Sumatera Utara WORK EXPERIENCES YEAR DESCRIPTION 2017 – Now Chief of Dermatology Cosmetic and Aesthetic Division, Departement of Dermatology Cosmetic and Aesthetic, Faculty of Medicine Universitas Sumatera Utara, Universitas Sumatera Utara Hospital Medan, H. Adam Malik General Hospital Medan 2019 – Now Member of the Board of Professors of Universitas Sumatera Utara 2017 – Now Member of the Advisory Council of Faculty of Medicine Universitas Sumatera Utara 2015 – Now Medical Sciences Doctorate Program Lecturer of Faculty of Medicine Universitas Sumatera Utara Medan 1997 – Now Lecturer of Faculty of Medicine USU Medan 2017 – 2021 Head of Department of Dermatology and Venereology, Faculty of Medicine Universitas Sumatera Utara 2017 – 2021 Head of Medical Staff Group of Dermatology and Venereology, Faculty of Medicine Universitas Sumatera Utara, Universitas Sumatera Utara Hospital Medan 2004 - 2007 Secretary of Department of Dermatology and Venereology Faculty of Medicine USU, Medical Functional Staff of RSUP H. Adam Malik ORGANIZATION HISTORY YEAR ORGANIZATIONS AND POSITIONS 2021 - Now Executive Board of Kolegium Dermatologi dan Venereologi Indonesia (KDVI)/ Indonesian Collegium of Dermatology and Venereology 2021 - Now Advisory Council of Ikatan Dokter Indonesia (IDI)/Indonesian Medical Association in North Sumatra Region 2021 – Now Advisory Council of Perhimpunan Kedokteran Wisata Kesehatan Indonesia (PERKEDWI)/ Indonesian Health Tourism Medical Association in North Sumatra Region. 2022 - Now Council of Expert of Perkumpulan Disiplin Herbal Medik Indonesia (PDHMI)/ Indonesian Medical Herbal Discipline Association in Sumatra 2022 - Now Advisory Council of Perhimpunan Dokter Spesialis Kulit dan Kelamin Indonesia (PERDOSKI)/ Indonesian Society of Dermatology and Venereology in Medan 2021 - Now Advisory Council of Kelompok Studi Dermatologi Sosial Indonesia/ Indonesian Social Dermatology Study Group 2017 – Now Head of Medical Education and Training, Ikatan Dokter Indonesia (IDI)/ Indonesian Medical Association in Medan 1998 - Now Member of PERDOSKI Medan Until now Member of IDI Medan Until now Member of Kelompok Studi Dermatologi Kosmetik Indonesia/ Indonesian Cosmetic Dermatology Study Group Until now Member of Kelompok Studi Dermatologi Anak Indonesia/ Indonesian Pediatric Dermatology Study Group Until now Member of Kelompok Studi LASER Indonesia/ Indonesian LASER Study Group Until now Member of Kelompok Studi Geriatri Indonesia/ Indonesian Geriartry Study Group Until Now Member of Kelompok Studi Dermatologi Sosial Indonesia/ Indonesian Social Dermatology Study Group PUBLICATIONS N° PUBLICATIONS 1. Assessing Acne Severity: Teledermatology Versus Face to Face Consultations During the COVID-19 Pandemic. In; J Clin Aesthet Dermatol. 2023;16(1):30-34. https://jcadonline.com/acne-severity-teledermatology-covid-pandemic/ 2. The Relationship of The Use of Mask with The Event of Maskne on USU Hospital Healthcare Workers During The COVID-19 Pandemic. In; Bali Med J, 2023, Volume 12, Number 2, 1171 – 1174. Doi:  https://doi.org/10.15562/bmj.v12i2.3967 e-ISSN: 2302-2914 3. Analysis of Risk Factors Associated with Maskne in the Era of the COVID-19 Pandemic. In; Sumatera Medical Journal (SUMEJ)., Vol. 6, N0.1, 2023. Doi: https://doi.org/10.32734/sumej.v6i1.8015 4. Correlation between Sebum Level and Follicular Fluoresence in Acne Vulgaris Patients. In; Open Acces Maced J Med Sci, E-ISSN: 1857-9655. 2022 April 12; 10(B): 1202-1205. E-ISSN: 1857-9655. Doi: https://doi.org/10.3889/oamjms.2022.9445 5. Bacterial sensitivity pattern to antibiotics in acne vulgaris at Universitas Sumatera Utara Hospital Medan, Indonesia in 2019. In; Journal of General Procedural Dermatology and Venereology Indonesia, 2022; 6(1). Doi:  http://dx.doi.org/10.19100/jdvi.v6i1.254 6. A Case Report The Evaluation of Malondialdehyde Level on Acne Vulgaris Treatment. In; Sumatera Medical Journal (SUMEJ)., Vol.5, No.2, 2022. Doi: https://doi.org/10.32734/sumej.v5i2.6633 7. Correlation Between Stress Scale and Serum Substance P Level in Acne Vulgaris. In; International Journal of General Medicine, 2021 Mar: (14)681-686, doi: https://doi.org/10.2147/IJGM.S294509 8. Cell Phone Acne: New Acne Clinical Features in the Coronavirus Disease-19 Era. In: Open Acces Maced J Med Sci, E-ISSN: 1857-9655. 2021 Oct; 9(F): 481-485. Doi: https://doi.org/10.3889/oamjms.2021.6872 9. Lower facial skin hydration level increases acne vulgaris severity. In; Bali Med J, 2021 December, Volume 10, Number 3: 1081-1084. Doi: 10.15562/bmj.v10i3.2195 e-issn: 23022914 10. Comparison between the diagnosis of acne vulgaris by teledermatology and face-to-face consultations. In; Bali Med J, 2021 December, Volume 10, Number 3: 1037-1040. Doi: 10.15562/bmj.v10i3.2792 e-issn: 23022914 11. Comparison of brain-derived neurotropic factor (BDNF) serum level in inflammatory and non-inflammatory acne vulgaris. In; Bali Med J, 2021 July Vol 10 (2); 659 – 662. doi: 10.15562/bmj.v10i2.2438 e-issn: 23022914 12. Intense pulsed light (IPL) as adjuvant therapy for acne vulgaris: A case series. In; Journal of General Procedural Dermatology and Venereology Indonesia, 2021; 5(3). Doi: http://dx.doi.org/10.19100/jdvi.v5i3.226 13. Plasma malondialdehyde levels related to acne vulgaris severity. In; Journal of General Procedural Dermatology and Venereology Indonesia, 2021; 5(3). Doi: http://dx.doi.org/10.19100/jdvi.v5i3.262 14. Alternative modality in the treatment of acne vulgaris: Low level laser therapy. In; Journal of General Procedural Dermatology and Venereology Indonesia, 2021; 5(2); 121-129. Doi: http://dx.doi.org/10.19100/jdvi.v5i2.168  15. Antibacterial Activity of Passion Fruit Purple Variant (Passiflora edulis Sims var. edulis) Seeds Extract Against Propionibacterium acnes In: Clinical, Cosmetic, and Investigational Dermatology. 2020; 13: 99-104. Doi: https://doi.org/10.2147/CCID.S229743 16. Passion fruit purple variant (Passiflora edulis Sims var. edulis) seeds extract 10% cream in acne vulgaris treatment: an open-label pilot study. In: International Journal of Dermatology. 2020; 59(12); 1506-12. Doi: https://doi.org/10.1111/ijd.15178 17. The Effect of Forkhead Box Class O1, Mammalian Target of Rapamycin Complex 1, Survivin, and Interleukin-17 on the Degree of Acne Vulgaris Based on Serum Levels. In: Open Access Macedonian Journal of Medical Sciences. 2020; 8(B): 401-407. Doi: https://doi.org/10.3889/oamjms.2020.3522 18. The Association Between Skin Types and Acne Vulgaris. In: Sumatera Medical Journal (SUMEJ). 2020; 3(1): 34-40. Doi: https://doi.org/10.32734/sumej.v3i1.3279 19. The Role of Digital Fluorescence in Acne Vulgaris: Correlation of Ultraviolet Red Fluorescence with the Severity of Acne Vulgaris. In: Dermatology Research and Practice. 2019;1-4. Doi: https://doi.org/10.1155/2019/4702423 20. A Case Series: A Successful of Alternative Modality with Red Light Low Level Laser Therapy for Acne Vulgaris. In Proceedings of the 2nd International Conference on Tropical Medicine and Infectious Disease (ICTROMI).2019; p.402-406. Doi: https://doi.org/10.5220/0009990204020406 21. The Effect of Oral Probiotic on the Interleukin-10 Serum Levels of Acne Vulgaris. In: Open Access Macedonia Journal of Medical Sciences. 2019; 7(19): 3249-52. Doi: https://doi.org/10.3889/oamjms.2019.718 20. Association of Serum Interleukin-10 (IL-10) with the Severity of Acne Vulgaris. In: Bali Medical Journal. 2019; 8(3): 573-6. Doi: https://doi.org/10.15562/bmj.v8i3.1514 21. No Association Between Lipid Profiles and Acne Vulgaris. In: Molecular and Cellular Biomedics. 2018; 2(2): 70-2. Doi: https://doi.org/10.21705/mcbs.v2l2.33 2 Certificate of Merit for Best Contributor of Intellectual Property/PATENTS from Faculty of Medicine USU 3 Republic of Indonesia Presidential Honors Grant Satyalancana Karya Satya XX 4 Scholarship World Congress of Dermatology, Milan, Italy 5 Awardee for the title of Fellow Asian Academy of Dermatology and Venereology (FAADV) 6 Awardee for the title of Fellow of The Indonesia Society of Dermatologyand Venereology (FINSDV) 7 Certificate of Appreciation for Outstanding Lecturer I at Universitas Sumatera Utara 8 Certificate of Appreciation for Outstanding Lecturer I at Faculty of Medicine Universitas Sumatera Utara 9 Republic of Indonesia Presidential Honors Grant Satyalancana Karya Satya X PATENTS AND INTELECTUAL PROPERTIES 1 “Broccoli Flower Extract (Brassica oleracea L. var italica Plenck) Used for Skin Anti-aging by Increasing the Expression of Type 1 mRNAProcolagen”. Patent number : IDP000060866, Status: Granted, Accepted: 23 Maret 2018 signed by: on the behalf of Minister of Law and Human Rights, Director General of Intellectual Property. 2 “Broccoli Flower Extract (Brassica oleracea L. var italica Plenck) Used for Skin Anti-aging by Decreasing the Expression of mRNA and MMP-1”. Patent number: IDP000060865, Status: Granted, Accepted: 23 Maret 2018 signed by: on the behalf of Minister of Law and Human Rights, Director General of Intellectual Property.

Source event

Event thumbnail

World Skin Health Day | Guinea 2024

Dear Colleagues & Partners,


Welcome to World Skin Health Day | Guinea 2024 !



Let us analyse the positive impact of World Skin Health Day | Guinea 2024 on event day: Access the Event Report.



For its forth edition, the World Skin Health Day is celebrated in Guinea under the auspice of the International League of Dermatological Societies (ILDS) and the International Society of Dermatology (ISD), and introduced by the World Health Organisation (WHO). Expected more than 300+ scientific presentations of Thought-Leaders from 40+ countries covering 22 topics, CME accredited by UEMS-EACCME® for ECMEC®.


Skin disease is one of the most common human illnesses. According to the World Health Organization, over 900 million people are affected by skin diseases around the world at any time. Also, the WHO International Classification of Diseases 11th Revision (ICD-11) includes more than 2,000 skin or skin-related illnesses. World Skin Health Day is a joint project of the International League of Dermatological Societies (ILDS) and the International Society of Dermatology (ISD). Since 2013, World Skin Health Day has been taking place across the world to raise awareness of and treat a diverse range of skin conditions. Taking part in World Skin Health Day helps to raise awareness about the wide-ranging impact of skin disease, as well as supporting people needing treatment in their local communities. To learn more about the campaign, please visit https://www.worldskinday.org


Since 2021, Gamal Abdel Nasser University and Clinique Dermatologique of Conakry conduct World Skin Health Day activities free of charge and open to the public or non-dermatological healthcare workers. In the 2021 edition, more than 500 people from the community of the Loos islands (KASSA) received free skin care with distribution of medicines. Highlighted on ILDS media and ISD Journal (Spring 2021) Vol. 15, No. 1 (p. 19). In the 2022 edition, 277 albinos at John Paul II hospital received free care with treatment of pre-cancerous lesions using trichloroacetic acid and free distribution of sunscreen received from our partner INOYAH. Highlighted on ILDS media and ISD Journal (Fall 2021) Vol. 15, No. 2 (p.15). In the 2023 edition, more than 900 people from the community of Boké perfecture received free skin care with distribution of medicines in September. In 2024, Université La Source and Clinique Dermatologique of Conakry invite you to support to WSHD | Guinea 2024 to raise awareness of and to improve access to dermatological services and treatments for a diverse range of skin conditions in Guinea


From January 27 to 31, 2024, WSHD | Guinea 2024 promises to be enlightening and transformative, featuring an array of themes ranging from cutting-edge diagnostics and therapeutics to the intersection of digital health in dermatology. Together, we will recognize and promote skin health worldwide.



Scientific Committee:


Prof. Brigitte DRENO MD PhD (Chair)

Prof. Jean BOLOGNIA MD (co-Chair)

Prof. Dedee MURRELL MD PhD

Prof. Hassan GALADARI MD

Prof. H. Peter SOYER MD, FACD FAHMS

Prof. Asmahen SOUISSI, MD

Prof. Somesh GUPTA MD

Prof. Nejib DOSS MD

Prof. Fahafahantsoa RAPELANORO RABENJA, MD

Prof. Monika FIDA MD

Prof. Franco RONGIOLETTI MD

Prof. Samira ZOBIRI MD

Prof. Aldo MORRONE

Prof. Giovanni DAMIANI, MD, PhD

Prof.George KROUMPOUZOS,MD,PhD

Dr. Nazim Khaled BENMEHIDI

Prof. Amor KHACHEMOUNE MD, PhD

Prof. Enas ATTIA MD

Prof. Mohsin AL-DHALIMI MD

Prof. Hamida TURKI MD

Prof. Dominique TENNSTEDT MD

Dr. Mathilde IORIZZO, MD, PhD, FMH

Prof. Mohammad JAFFERANY MD, PhD

Prof. Aimilios LALLAS MD, MSc, PhD

Prof.Georgi TCHERNEV,MD,PhD

Prof. Esther FREEMAN MD PhD



Join us in making a difference and explore our diverse themes:


Theme 1 : Acne and Rosacea : Diagnostics and therapeutics / Acné et Rosacea : Diagnostic et thérapeutique

Chair : Pr Brigitte DRENO MD PhD (France)

Theme 2 : Atopic Dermatitis and allergology / Dermatite atopique et allergologie

Chair : Pr Alain Taieb MD (France) ; Pr Kiran V. Godse MD, PhD (Glasg.)

Theme 3 : Psoriasis : Diagnosis and therapeutic / Psoriasis : Diagnostic et thérapeutique

Chair : Pr Giovanni Damiani MD, PhD

Theme 4 : Pigmentation diagnostics and therapeutics / Diagnostic et thérapeutique de la pigmentation

Chairs : Pr Firas AL-NIAIMI MD; Pr. Rashmi SARKAR MD, FAMS, IFAAD

Theme 5 : Cosmetic Dermatology / Dermatologie Cosmétique

Chairs : Pr. George KROUMPOUZOS MD, PhD, FAAD; Prof. Robert A. Schwartz MD, MPH, DSc (Hon), FRCP Edin (USA)

Theme 6 : Dermatosurgery / Dermato – Chirurgie

Chairs : Pr Amor KHACHEMOUNE MD PhD FAHMS; Pr H. Peter SOYER MD, FACD; Dr. Khaled TURKI MD

Theme 7 : Hair disorders / Troubles capillaires

Chairs : Dr. Sergio Vano-Galvan, MD, PhD; Dr Maria-Angeliki GKINI, MD, MSc, PhD; Pr Asmahen Souissi MD

Theme 8 : Nail disorders / Troubles des ongles

Chair : Pr Chander Grover MD

Theme 9 : Pediatric Dermatology / Dermatologie pédiatrique

Chairs : Pr Dominique TENNSTEDT MD; Pr Hamida TURKI MD

Theme 10 : Psychodermatology / Psychodermatologie

Chair : Pr. Mohammad JAFFERANY MD, PhD

Theme 11 : Sexually transmitted diseases and dermatology in the genital area / Maladies sexuellement transmissibles et dermatologie dans la région génitale

Chairs : Dr Antoine BERTOLOTTI MD, PhD; Dr Sandra LY MD

Theme 12 : Medical dermatology / Dermatologie médicale

Chairs : Pr Jean BOLOGNIA MD; Pr Michel Gillet MD PhD; Pr Néjib DOSS MD; Pr Monika FIDA MD

Theme 13 : Dermoscopy / Dermoscopie

Chair : Pr. Aimilios LALLAS MD MSc; Pr. John PAOLI MD; Dr Michela Vita Rita Starace MD PhD; Dr Nazim BENMEHIDI MD

Theme 14 : Virtual exhibition / Exposition virtuelle

Chair : Pr Kelati AWATEF MD

Theme 15 : Skin NTDs

Chairs : Prof. Rapelanoro Rabenja Fahafahantsoa MD; Pr. Mokni Mourad MD; Dr. Ruiz Postigo José Antonio

Theme 16 : Discussion session / Session discussion

WHO Perspectives – OpenWHO and medical education – GLODERM Mentorship

Panelists : José-Antonio Ruiz-Postigo; Kari Wanat; Esther FREEMAN

Theme 17 : ISD Mentorship Program

Panelists : Nellie Konnikov; Leopoldo Santos; Martin Kassir

Theme 18 : GLODERM Mentees

Chairs : Kari Wanat; Esther FREEMAN

Theme 19 : Residents symposium

Chair : Pr Siham Dikhaye MD

Theme 20 : Vesiculobullous diseases + Others – Maladies vésiculo-bulleuses + Autres

Chair : Pr. Dedee MURRELL MD PhD DSc



Thank you for your invaluable support in advancing skin health on a global scale. Together, we can inspire change and transform lives.


Dr Ibrahima TRAORE, Organizer, WSHD | Guinea 2024

January 27, 2024Live Event
View full event

Description

Acne vulgaris and rosacea are two chronic inflammatory skin conditions that primarily affect the facial area. Both may cause significant psychological problems and reduce patient’s quality of life. Acne vulgaris has multifactorial etiopathogenesis so that the treatment should be done by holistic approach. New formulations derived from herbal ingredients for acne treatment are especially targeting the inflammatory cascade, antimicrobial effect, and reduce sebum production.  Encouraging the use of dermocosmetic in synergy with pharmacological regiment should support improved acne treatment adherence in better clinical outcomes. Rosacea has complex pathogenesis but that is not fully understood, involves dysfunction of immune system, dysregulation of neurovascular, presence of microorganism and environmental factors. The care of rosacea skin is a challenge for dermatologists. It features may be reduced or controlled with a range of pharmacological and procedural therapies as well as skin care and lifestyle management. Combination therapy is often necessary for effective treatment. Keywords: acne vulgaris, dermocosmetics, herbal therapy, rosacea

Similar videos

Loading...

Source event Program

09:15 - 09:35
Partner image

Welcome speech

Fodé Mohamed PhD

09:35 - 09:45
Partner image

Introduction

Dr. José-Antonio Ruiz-Postigo qualified from the Medical School of Autonomous University of Barcelona, Catalonia, Spain. He is a post-graduate holder in Tropical Medicine and International Health, and he further pursued his interest in research by completing his PhD at the University of Barcelona. His thesis was on the epidemiology and control of human African trypanosomiasis in the municipality of Kissama, Angola. He has been working on Neglected Tropical Diseases (NTDs) for 28 years, mainly in sub-Saharan Africa and the WHO Eastern Mediterranean Region. Since 2013, he is based at WHO headquarters where he led the World Leishmaniasis Control Programme for the period 2016-2019. In 2020 he joined the newly created team on Skin Neglected Tropical Diseases at WHO headquarters. Since then, his main work has been related to the creation of the WHO mobile app on Skin NTDs, which includes a section on artificial intelligence, alongside the establishment of a channel for online courses at OpenWHO and the implementation of a global web-based surveillance at WHO for data collection, analysis and dissemination on leishmaniasis and skin NTDs.
09:45 - 09:54
Partner image

Introduction to the René Touraine Foundation

Le professeur René Touraine est à l’origine de la recherche clinique et thérapeutique en dermatologie en France. Un de ses élèves, le Professeur Louis Dubertret, crée en 1991 la fondation portant son nom. La FRT est une Fondation reconnue d’utilité publique et une organisation internationale à but non lucratif. Son objectif est de soutenir le progrès thérapeutique en dermatologie pour aider les patients à accéder à des soins de qualité dans leur pays. La Fondation adopte une approche multidisciplinaire et réunit tant sur le terrain qu’au niveau international des chercheurs, des dermatologues, des associations de patients, des industries pharmaceutiques et cosmétiques et des autorités sanitaires.

Session 1 : Acne and Rosacea : Diagnostics and therapeutics / Acné et Rosacea : Diagnostics et Thérapeutiques

Partner image

Le microbiome cutanée : Gardien de la bonne santé de notre peau / The skin microbiome: Guardian of the good health of our skin

National Academy of Medicine Division: Medicine and medical specialties (France) Total publications (since 1977): 918 h factor: 66. SCI (Without self citations): 31566. SIGAPS score: 8954 UNIVERSITY TITLES 2016 President of the CNU – Dermatology – 50th section – 3rd subsection (Nantes, France) 2013 Elected member of the National Council of Universities – Dermatology – 50 th section – 3 rd sub-section 2011 University Professor Exceptional class 2nd level HOSPITAL TITLES AND FUNCTIONS Since 2014 Head of Department of Dermato-Cancerology Since 1993 Founder and Director of the Cellular and Gene Therapy Unit (UTCG) of the University Hospital of Nantes HONORABLE DISTINCTIONS 2015 Appointment to the rank of Knight in the Order of Academic Palms 2013 2013 International League of Dermatological Societies (ILDS) Award 2005 Prize for Victories in medicine, specialty “Cancerology” ACADEMIC RESPONSIBILITIES Since 2020 Deputy Vice-President for Scientific and Technical Culture at the University of Nantes Since 2012 Director of group 2 “Translational and clinical research on melanoma” within the Cancer Research Center (CRCINA U1232) in Nantes 2011 – 2020 Vice-Dean for Research of the Faculty of Medicine of Nantes Since 2005 Founder and Coordinator of the Biotherapy Module of the Clinical Investigation Center of Biotherapy INSERM CBT0503 OTHER DUTIES AND RESPONSIBILITIES 2021 Sponsor of the association ELLES à la Santé 2018 Elected president of the committee in charge of the scientific program of the annual congress of the Academy: European Academy of Dermatology and Venereology (European Academy of Dermatology and Venereology) (EADV) 2015 Elected Board Member and Treasurer of the International League of Dermatological Societies (ILDS) which coordinates Dermatology societies on a global level and ensures relations with the WHO for skin conditions ACADEMIC SOCIETIES 2019 Founding Member and Member of the Board of Directors of the French Society of Cancer Immunotherapy (FITC) 2016 Chair of the scientific committee in charge of the scientific program of the EADV 2014 Founding Member of the “Melanoma Word Society” (MWS) 2015 Treasurer of the ILDS 2014 Member of the scientific committee of the European Society of Dermatology (EADV) 2010 -2012 President of the College of Teachers of Dermatology of France (CEDEF) 2004 – 2006 President of the French Society of Dermatology (SFD). Vice-President of the French Society of Dermatology: 2003 Member of the Board of Directors: 2002 2002 – 2005 Founding member of the French Society of Cellular and Gene Therapy 2009 Board member of the “Skin Cancer Foundation” 2005 Foreign member of the Canadian Society of Dermatology 1994 Full member of the “International Society for Cutaneous Lymphomas” (ISCL). Member of the Office from 2000 to 2010 1990 Full Member of the American Academy of Dermatology (AAD) 1987 Full Member of the “European Society for Dermatological Research” (ESDR) 1982 Founding member of the French Society for Research in Dermatology (SRD). Board member: 1989 to 1992 CONGRESS ORGANIZATION European Congresses: 2011 Organizer and Session Chair of the 7th European Association of Dermatology Oncology – Nantes – (EADO)
Partner image

International expert consensus recommendations for use of dermo- cosmetics in acne

Delphine KEROB

Partner image

Acné et qualité de vie des adolescents à peau pigmentée en milieu scolaire à Abidjan, Côte d'Ivoire (Afrique subsaharienne) / Acne and quality of life in adolescents with pigmented skin in a school environment in Abidjan, Ivory Coast (Sub- Saharan Africa)

TITRES ET DIPLOMES -Maître de conférences agrégé CAMES en Dermatologie-vénérologie, UFR des Sciences Médicales de l’université Félix Houphouët Boigny d’Abidjan. -Maîtrise professionnalisée de Santé Publique à l’UFR Sciences Pharmaceutiques et biologiques de l’université Félix Houphouët Boigny -Diplôme inter universitaire (DIU) sur les maladies systémiques à expression cutanée de l’Université Pierre Marie Curie de Paris. -Diplôme inter universitaire (DIU) de dermatologie esthétique, lasers et cosmétologie de l’université de Bordeaux. -CES (Certificat d’études spéciales) de Dermatologie Vénérologie de l’UFR Sciences médicales d’Abidjan, université Félix Houphouët Boigny FONCTIONS 2023 : -Chef unité A d’hospitalisation du service de Dermatologie du CHU de Treichville -Responsable des stages du Diplôme d’études spéciales en dermatologie Vénérologie de l’UFR Sciences médicales d’Abidjan, université Félix Houphouët Boigny Depuis 2010 : -Praticien hospitalier au service de Dermatologie Vénérologie du CHU de Treichville Abidjan -Ancien Interne des hôpitaux d’Abidjan -Enseignant chercheur à l’UFR Sciences médicales d’Abidjan, université Félix Houphouët Boigny SOCIETES SAVANTES, CULTURELLES OU SCIENTIFIQUES -Membre de la Société Ivoirienne de Dermatologie-Vénérologie (SIDV) -Membre de l’Association des Dermatologues Francophones (ADF) -Membre de la Société de Dermatologie D’Afrique Francophone (SODAF) -Membre de la Sociéte Française de Dermatologie (SFD) Date :14/12/2023 Certifié sincère Signature :
Partner image

Long-term treatment for acne

Dr Peter Ch'ng is a consultant dermatologist and skin specialist who always put his patients' safety and wellbeing as his top priority. As an esteemed dermatologist and skin specialist, Dr Peter prides himself in being able to treat acne patients of all types, with a 100% acne treatment success record. He is Vice President for Malaysian Leprosy Relief Association Pahang, Member of Dystrophic Epidermolysis Bullosa Research Association (DEBRA) International, EXCO Member of Malaysia Dermatology Association and Member of Cochrane Skin Group
Partner image

Unveiling Current Insights on Acne Vulgaris and Rosacea

Year Education Program 1993 Medical Doctor, Faculty of Medicine Universitas Sumatera Utara 2001 Specialist of Dermatology Venereology and Aesthetic, Faculty of Medicine Universitas Sumatera Utara 2006 Advance Dermatology, National Skin Centre, Singapore 2008 Consultant of Cosmetic and Aesthetic Dermatology, Kolegium Dermatologi dan Venereologi (KDVI)/ Indonesian Collegium of Dermatology and Venereology 2012 Doctorate degree in Medical Sciences, Faculty of Medicine Universitas Sumatera Utara WORK EXPERIENCES YEAR DESCRIPTION 2017 – Now Chief of Dermatology Cosmetic and Aesthetic Division, Departement of Dermatology Cosmetic and Aesthetic, Faculty of Medicine Universitas Sumatera Utara, Universitas Sumatera Utara Hospital Medan, H. Adam Malik General Hospital Medan 2019 – Now Member of the Board of Professors of Universitas Sumatera Utara 2017 – Now Member of the Advisory Council of Faculty of Medicine Universitas Sumatera Utara 2015 – Now Medical Sciences Doctorate Program Lecturer of Faculty of Medicine Universitas Sumatera Utara Medan 1997 – Now Lecturer of Faculty of Medicine USU Medan 2017 – 2021 Head of Department of Dermatology and Venereology, Faculty of Medicine Universitas Sumatera Utara 2017 – 2021 Head of Medical Staff Group of Dermatology and Venereology, Faculty of Medicine Universitas Sumatera Utara, Universitas Sumatera Utara Hospital Medan 2004 - 2007 Secretary of Department of Dermatology and Venereology Faculty of Medicine USU, Medical Functional Staff of RSUP H. Adam Malik ORGANIZATION HISTORY YEAR ORGANIZATIONS AND POSITIONS 2021 - Now Executive Board of Kolegium Dermatologi dan Venereologi Indonesia (KDVI)/ Indonesian Collegium of Dermatology and Venereology 2021 - Now Advisory Council of Ikatan Dokter Indonesia (IDI)/Indonesian Medical Association in North Sumatra Region 2021 – Now Advisory Council of Perhimpunan Kedokteran Wisata Kesehatan Indonesia (PERKEDWI)/ Indonesian Health Tourism Medical Association in North Sumatra Region. 2022 - Now Council of Expert of Perkumpulan Disiplin Herbal Medik Indonesia (PDHMI)/ Indonesian Medical Herbal Discipline Association in Sumatra 2022 - Now Advisory Council of Perhimpunan Dokter Spesialis Kulit dan Kelamin Indonesia (PERDOSKI)/ Indonesian Society of Dermatology and Venereology in Medan 2021 - Now Advisory Council of Kelompok Studi Dermatologi Sosial Indonesia/ Indonesian Social Dermatology Study Group 2017 – Now Head of Medical Education and Training, Ikatan Dokter Indonesia (IDI)/ Indonesian Medical Association in Medan 1998 - Now Member of PERDOSKI Medan Until now Member of IDI Medan Until now Member of Kelompok Studi Dermatologi Kosmetik Indonesia/ Indonesian Cosmetic Dermatology Study Group Until now Member of Kelompok Studi Dermatologi Anak Indonesia/ Indonesian Pediatric Dermatology Study Group Until now Member of Kelompok Studi LASER Indonesia/ Indonesian LASER Study Group Until now Member of Kelompok Studi Geriatri Indonesia/ Indonesian Geriartry Study Group Until Now Member of Kelompok Studi Dermatologi Sosial Indonesia/ Indonesian Social Dermatology Study Group PUBLICATIONS N° PUBLICATIONS 1. Assessing Acne Severity: Teledermatology Versus Face to Face Consultations During the COVID-19 Pandemic. In; J Clin Aesthet Dermatol. 2023;16(1):30-34. https://jcadonline.com/acne-severity-teledermatology-covid-pandemic/ 2. The Relationship of The Use of Mask with The Event of Maskne on USU Hospital Healthcare Workers During The COVID-19 Pandemic. In; Bali Med J, 2023, Volume 12, Number 2, 1171 – 1174. Doi:  https://doi.org/10.15562/bmj.v12i2.3967 e-ISSN: 2302-2914 3. Analysis of Risk Factors Associated with Maskne in the Era of the COVID-19 Pandemic. In; Sumatera Medical Journal (SUMEJ)., Vol. 6, N0.1, 2023. Doi: https://doi.org/10.32734/sumej.v6i1.8015 4. Correlation between Sebum Level and Follicular Fluoresence in Acne Vulgaris Patients. In; Open Acces Maced J Med Sci, E-ISSN: 1857-9655. 2022 April 12; 10(B): 1202-1205. E-ISSN: 1857-9655. Doi: https://doi.org/10.3889/oamjms.2022.9445 5. Bacterial sensitivity pattern to antibiotics in acne vulgaris at Universitas Sumatera Utara Hospital Medan, Indonesia in 2019. In; Journal of General Procedural Dermatology and Venereology Indonesia, 2022; 6(1). Doi:  http://dx.doi.org/10.19100/jdvi.v6i1.254 6. A Case Report The Evaluation of Malondialdehyde Level on Acne Vulgaris Treatment. In; Sumatera Medical Journal (SUMEJ)., Vol.5, No.2, 2022. Doi: https://doi.org/10.32734/sumej.v5i2.6633 7. Correlation Between Stress Scale and Serum Substance P Level in Acne Vulgaris. In; International Journal of General Medicine, 2021 Mar: (14)681-686, doi: https://doi.org/10.2147/IJGM.S294509 8. Cell Phone Acne: New Acne Clinical Features in the Coronavirus Disease-19 Era. In: Open Acces Maced J Med Sci, E-ISSN: 1857-9655. 2021 Oct; 9(F): 481-485. Doi: https://doi.org/10.3889/oamjms.2021.6872 9. Lower facial skin hydration level increases acne vulgaris severity. In; Bali Med J, 2021 December, Volume 10, Number 3: 1081-1084. Doi: 10.15562/bmj.v10i3.2195 e-issn: 23022914 10. Comparison between the diagnosis of acne vulgaris by teledermatology and face-to-face consultations. In; Bali Med J, 2021 December, Volume 10, Number 3: 1037-1040. Doi: 10.15562/bmj.v10i3.2792 e-issn: 23022914 11. Comparison of brain-derived neurotropic factor (BDNF) serum level in inflammatory and non-inflammatory acne vulgaris. In; Bali Med J, 2021 July Vol 10 (2); 659 – 662. doi: 10.15562/bmj.v10i2.2438 e-issn: 23022914 12. Intense pulsed light (IPL) as adjuvant therapy for acne vulgaris: A case series. In; Journal of General Procedural Dermatology and Venereology Indonesia, 2021; 5(3). Doi: http://dx.doi.org/10.19100/jdvi.v5i3.226 13. Plasma malondialdehyde levels related to acne vulgaris severity. In; Journal of General Procedural Dermatology and Venereology Indonesia, 2021; 5(3). Doi: http://dx.doi.org/10.19100/jdvi.v5i3.262 14. Alternative modality in the treatment of acne vulgaris: Low level laser therapy. In; Journal of General Procedural Dermatology and Venereology Indonesia, 2021; 5(2); 121-129. Doi: http://dx.doi.org/10.19100/jdvi.v5i2.168  15. Antibacterial Activity of Passion Fruit Purple Variant (Passiflora edulis Sims var. edulis) Seeds Extract Against Propionibacterium acnes In: Clinical, Cosmetic, and Investigational Dermatology. 2020; 13: 99-104. Doi: https://doi.org/10.2147/CCID.S229743 16. Passion fruit purple variant (Passiflora edulis Sims var. edulis) seeds extract 10% cream in acne vulgaris treatment: an open-label pilot study. In: International Journal of Dermatology. 2020; 59(12); 1506-12. Doi: https://doi.org/10.1111/ijd.15178 17. The Effect of Forkhead Box Class O1, Mammalian Target of Rapamycin Complex 1, Survivin, and Interleukin-17 on the Degree of Acne Vulgaris Based on Serum Levels. In: Open Access Macedonian Journal of Medical Sciences. 2020; 8(B): 401-407. Doi: https://doi.org/10.3889/oamjms.2020.3522 18. The Association Between Skin Types and Acne Vulgaris. In: Sumatera Medical Journal (SUMEJ). 2020; 3(1): 34-40. Doi: https://doi.org/10.32734/sumej.v3i1.3279 19. The Role of Digital Fluorescence in Acne Vulgaris: Correlation of Ultraviolet Red Fluorescence with the Severity of Acne Vulgaris. In: Dermatology Research and Practice. 2019;1-4. Doi: https://doi.org/10.1155/2019/4702423 20. A Case Series: A Successful of Alternative Modality with Red Light Low Level Laser Therapy for Acne Vulgaris. In Proceedings of the 2nd International Conference on Tropical Medicine and Infectious Disease (ICTROMI).2019; p.402-406. Doi: https://doi.org/10.5220/0009990204020406 21. The Effect of Oral Probiotic on the Interleukin-10 Serum Levels of Acne Vulgaris. In: Open Access Macedonia Journal of Medical Sciences. 2019; 7(19): 3249-52. Doi: https://doi.org/10.3889/oamjms.2019.718 20. Association of Serum Interleukin-10 (IL-10) with the Severity of Acne Vulgaris. In: Bali Medical Journal. 2019; 8(3): 573-6. Doi: https://doi.org/10.15562/bmj.v8i3.1514 21. No Association Between Lipid Profiles and Acne Vulgaris. In: Molecular and Cellular Biomedics. 2018; 2(2): 70-2. Doi: https://doi.org/10.21705/mcbs.v2l2.33 2 Certificate of Merit for Best Contributor of Intellectual Property/PATENTS from Faculty of Medicine USU 3 Republic of Indonesia Presidential Honors Grant Satyalancana Karya Satya XX 4 Scholarship World Congress of Dermatology, Milan, Italy 5 Awardee for the title of Fellow Asian Academy of Dermatology and Venereology (FAADV) 6 Awardee for the title of Fellow of The Indonesia Society of Dermatologyand Venereology (FINSDV) 7 Certificate of Appreciation for Outstanding Lecturer I at Universitas Sumatera Utara 8 Certificate of Appreciation for Outstanding Lecturer I at Faculty of Medicine Universitas Sumatera Utara 9 Republic of Indonesia Presidential Honors Grant Satyalancana Karya Satya X PATENTS AND INTELECTUAL PROPERTIES 1 “Broccoli Flower Extract (Brassica oleracea L. var italica Plenck) Used for Skin Anti-aging by Increasing the Expression of Type 1 mRNAProcolagen”. Patent number : IDP000060866, Status: Granted, Accepted: 23 Maret 2018 signed by: on the behalf of Minister of Law and Human Rights, Director General of Intellectual Property. 2 “Broccoli Flower Extract (Brassica oleracea L. var italica Plenck) Used for Skin Anti-aging by Decreasing the Expression of mRNA and MMP-1”. Patent number: IDP000060865, Status: Granted, Accepted: 23 Maret 2018 signed by: on the behalf of Minister of Law and Human Rights, Director General of Intellectual Property.
Partner image

Epidemiological and clinical profile of acne in Kinshasa / Profil épidémiologique et clinique de l’ acné a Kinshasa

Médecin dermatologue à Kinshasa en République Démocratique du Congo, Secrétaire General de la Société Congolaise de Dermatologie
Partner image

Advances in rosacea what is the current state of art

Dr. Maha is Board certified in aesthetic medicine from American academy of aesthetic medicine, she holds master degree in dermatology and venereology from Ain shams university, and diploma in laser and its application in dermatology from Cairo University. Diploma in skin cancer from Bond University Australia and professional certificate in dermoscopy Queensland University Australia. Dr. Maha is a member in the following societies European Academy of Dermatology (EADV), European Academy of Dermato-oncology (EADO), American Academy of Dermatology (AAD) and international dermoscopy society. Dr. Maha has worked in prestigious hospitals in Egypt, Kuwait before joining Mediclinic group UAE.
Partner image

Rosacea in skin of color

Clinical Professor and Consultant Dermatologist, De la Salle Health Sciences Institute and Medical Center. Manila Philippines
Partner image

DISCUSSIONS - ACNE AND ROSACEA

National Academy of Medicine Division: Medicine and medical specialties (France) Total publications (since 1977): 918 h factor: 66. SCI (Without self citations): 31566. SIGAPS score: 8954 UNIVERSITY TITLES 2016 President of the CNU – Dermatology – 50th section – 3rd subsection (Nantes, France) 2013 Elected member of the National Council of Universities – Dermatology – 50 th section – 3 rd sub-section 2011 University Professor Exceptional class 2nd level HOSPITAL TITLES AND FUNCTIONS Since 2014 Head of Department of Dermato-Cancerology Since 1993 Founder and Director of the Cellular and Gene Therapy Unit (UTCG) of the University Hospital of Nantes HONORABLE DISTINCTIONS 2015 Appointment to the rank of Knight in the Order of Academic Palms 2013 2013 International League of Dermatological Societies (ILDS) Award 2005 Prize for Victories in medicine, specialty “Cancerology” ACADEMIC RESPONSIBILITIES Since 2020 Deputy Vice-President for Scientific and Technical Culture at the University of Nantes Since 2012 Director of group 2 “Translational and clinical research on melanoma” within the Cancer Research Center (CRCINA U1232) in Nantes 2011 – 2020 Vice-Dean for Research of the Faculty of Medicine of Nantes Since 2005 Founder and Coordinator of the Biotherapy Module of the Clinical Investigation Center of Biotherapy INSERM CBT0503 OTHER DUTIES AND RESPONSIBILITIES 2021 Sponsor of the association ELLES à la Santé 2018 Elected president of the committee in charge of the scientific program of the annual congress of the Academy: European Academy of Dermatology and Venereology (European Academy of Dermatology and Venereology) (EADV) 2015 Elected Board Member and Treasurer of the International League of Dermatological Societies (ILDS) which coordinates Dermatology societies on a global level and ensures relations with the WHO for skin conditions ACADEMIC SOCIETIES 2019 Founding Member and Member of the Board of Directors of the French Society of Cancer Immunotherapy (FITC) 2016 Chair of the scientific committee in charge of the scientific program of the EADV 2014 Founding Member of the “Melanoma Word Society” (MWS) 2015 Treasurer of the ILDS 2014 Member of the scientific committee of the European Society of Dermatology (EADV) 2010 -2012 President of the College of Teachers of Dermatology of France (CEDEF) 2004 – 2006 President of the French Society of Dermatology (SFD). Vice-President of the French Society of Dermatology: 2003 Member of the Board of Directors: 2002 2002 – 2005 Founding member of the French Society of Cellular and Gene Therapy 2009 Board member of the “Skin Cancer Foundation” 2005 Foreign member of the Canadian Society of Dermatology 1994 Full member of the “International Society for Cutaneous Lymphomas” (ISCL). Member of the Office from 2000 to 2010 1990 Full Member of the American Academy of Dermatology (AAD) 1987 Full Member of the “European Society for Dermatological Research” (ESDR) 1982 Founding member of the French Society for Research in Dermatology (SRD). Board member: 1989 to 1992 CONGRESS ORGANIZATION European Congresses: 2011 Organizer and Session Chair of the 7th European Association of Dermatology Oncology – Nantes – (EADO)
Partner image

Symposium PIERRE FABRE : Acne Management with Keracnyl PP+ / Prise en Charge de l’Acné avec Keracnyl PP+ (CME-)

Chef produit Pierre Fabre Dermocosmétique et Personal Care

Session 2 : Atopic Dermatitis and allergology / Dermatite atopique et allergologie

Partner image

Mises à jour sur l'urticaire chronique / Updates in Chronic Urticaria

Emek Kocatürk Göncü is a Professor of Dermatology in Koç University School of Medicine in Istanbul, Turkey and a researcher in Charite University Insitute of Allergology, Berlin, Germany. Her clinical focus is in urticaria, contact/occupational dermatitis, itch, atopic dermatitis and psychodermatology. She is an author/co-author of more than 170 papers in peer-reviewed journals mostly on urticaria, atopic dermatitis and itch. Her recent research focuses on patient reported outcome tools in chronic urticaria, hormonal effects on urticaria, autoimmune urticaria, incoming drugs in urticaria, COVID-19 and urticaria and inducible urticarias. She is a member of many scientific societies and acts as a steering committee member of the UCARE Network.
Partner image

Dermatite atopique en Afrique subsaharienne: défi pour mettre en place la recherche / Atopic dermatitis in sub-Saharan Africa: challenge for implementing research

Docteur F RAPELANORO RABENJA Professeur Titulaire en Dermatologie-Allergologie- MST Ancien Chef de Clinique Assistant en Mdecine Interne Et Maladies Tropicales / DESS en Gestion de Projets Universit de Bordeaux II / Universit dAntananarivo
Partner image

Adult atopic dermatitis: clinical presentation

Professor Samira Zobiri Graduation from the university of Algiers Head of clinic of the dermatology department at Mustapha Hospital at Algiers Member of the Algerian society of dermatology Member of the European academy of dermatology and venereology Coordinator of the atopy school (atopic dermatitis) at Algiers Fields of interest: Atopic dermatitis, Acne, pediatric dermatology, Psoriasis
Partner image

Comorbidités de la dermatite atopique / Comorbidities of atopic dermatitis

Jonathan Silverberg is a Professor of Dermatology at The George Washington University School of Medicine and Health Sciences in Washington, DC. He is the Director of Clinical Research and Contact Dermatitis. Dr. Silverberg’s area of clinical subspecialty is inflammatory skin disease, particularly atopic and contact dermatitis. He has extensive experience in the advanced management of atopic dermatitis, hand eczema, chronic itch, psoriasis, hidradenitis and many other chronic inflammatory skin disorders. He is also a national expert in allergy patch testing, phototesting and photopatch testing. Dr. Silverberg’s research interests include the epidemiology of chronic and infectious diseases. His publications include more than 1000 peer-reviewed articles, abstracts and book chapters.
Partner image

Antihistamine resistant urticaria

Professor of dermatology Department of Dermatology, D.Y.Patil University & School of Medicine Navi Mumbai India 150 publications 7 books, 20 chapters President IADVL 2020 President skin allergy society India Editor in chief Indian journal of skin allergy
Partner image

Cours OpenWHO sur la dermatite atopique destiné aux agents de soins de santé primaires en Afrique subsaharienne : qu'est-ce quiOpenWHO course on atopic dermatitis for primary health care workers in Sub- Saharan Africa: what matters most in this setting?”

Alain Taïeb is professor emeritus of Dermatology at Bordeaux University. He established theNational Reference Centre for Rare Skin Disorders in 2005. He was until 2019 Director of INSERM 1035 research lab “Biotherapy of genetic diseases, inflammatory disorders and cancer” (BMGIC). He set up the European Task Force on Atopic Dermatitis in 1990, and the Vitiligo European Task Force in 2003, which are the current official ad hoc tasks forces of the EADV. He has authored more than 700 articles in peer-reviewed journals and more than 60 chapters in multiauthored books. In addition, he published “History of Atopic Dermatitis” with Dr Wallach and Tilles, in 2004, and two textbooks “Neonatal Dermatology” with Drs Enjolras, Wallach and Vabres (2009) and “Vitiligo” with Dr Picardo (2010- second edition 2019). His major topics of interest are pediatric dermatology, genodermatoses, atopic dermatitis, vitiligo and pigment cell disorders. He has received several awards and distinctions from the Society for Pediatric Dermatology, the European Society of Pediatric Dermatology, the International League of Dermatological Societies, the American Skin Association, and the European Society for Pigment Cell Research. H factor 68 (WoS). Dr Taïeb is currently President of the International Society of Atopic Dermatitis (ISAD).
Partner image

Pathophysiology and New Therapies in Atopic Dermatitis

Prof. Martin studied Medicine and Human Biology in Germany where he received his MD and PhD from University Marburg. He received his dermatology training at University in Muenster and Univ. California San Francisco. Professor Martin Steinhoff is now Chairman at the Dept. of Dermatology and Director of the Translational Research Institute as well as Residency Program Director at Hamad Medical Corporation, Qatar. He is Full-Professor at Weill-Cornell Universities in New York and Qatar, Hamad bin Khalifa University and Qatar University. Prof. Steinhoff’s main interest is neuroimmunology where his group described various new mechanisms like the first histamine-independent itch pathway, published in Nature Medicine, and described the first cytokine receptor on human sensory nerves which has led to development of new medications. Prof. Martin published around 300 peer-reviewed articles (H-index: 88), over 40 book chapters, and holds numerous patents. His research has been funded with >60 Mio Euro so far. His group received 2023 the PPM award to study precision medicine based pathways and new treatments for atopic dermatitis. Finally, Prof. Martin was also PI on various clinical trials and received several prestigious international research-awards, and is honorary member of several Societies for Dermatology.
Partner image

Education thérapeutique dans la Dermatite atopique / Therapeutical education in Atopic dermatitis

Célestin Ahogo MD

Session 3 : Psoriasis : Diagnosis and therapeutic / Psoriasis : Diagnostic et thérapeutique

Partner image

Répondre aux besoins non satisfaits des patients psoriasiques dans les pays en développement / Addressing the unmet needs of psoriatic patients in developing countries

Professional education Medical Doctor: Faculty of Medicine, Diponegoro University, Semarang, Indonesia (2004). Specialist in Dermato-Venereology-Aesthetic : Faculty of Medicine, Diponegoro University, Semarang, Indonesia (2009) Consultant in Dermato-Allergy-Immunology: 2022   Professional experience Home staff and board-certified Specialist in Dermato-Venereology-Aesthetic in Dr Kariadi General Hospital – Semarang, Indonesia (2010 to present) Lecturer in Department of Dermato-Venereology-Aesthetic, Faculty of Medicine, Diponegoro University, Semarang, Indonesia (2010 to present) Member of Indonesian Doctor Association (2004 to present) Member of Indonesian Dermato-Venereologist-Aesthetician Society (2005 to present) Member and scientific committee of Indonesian Psoriasis Study Group (2010 to present)
Partner image

Traitement du psoriasis chez les patients atteints d'infections chroniques / Treatment of psoriasis in patients with chronic infections

Prof. Tiago Torres is a distinguished Professor of Dermatology at the Instituto de Cincias Biomdicas Abel Salazar, University of Porto. He obtained his medical degree from the Faculdade de Medicina, University of Porto, and completed a residency program in Dermatology and Venereology at Centro Hospitalar Universitrio do Porto (CHUP). In 2014, he completed his PhD thesis, investigating the role of systemic inflammation associated with psoriasis in atherosclerosis. Currently, he leads the psoriasis and atopic dermatitis Unit at CHUP. Prof. Torres has been actively involved in developing national treatment guidelines and has received numerous accolades, including research grants and prizes from the Portuguese Society of Dermatology and Venerology. He serves as an associate editor and co-editor for prestigious medical journals and is a member of various international dermatology organizations. With over 100 published articles and editorship of a book, his research focuses on immunodermatology and the immunology and immunopharmacology of psoriasis and atopic dermatitis.
Partner image

Dilemme diagnostique du psoriasis sur peau de couleur / Diagnostic dilemma of psoriasis in skin of color

Designation:   MBBS, MPH, DDSc (UK), MSc-Derm (UK) Affiliation: Psoriasis Awareness Club Bangladesh President, Psoriasis Awareness Club, Banggladesh Councilor, International Psoriasis council Many national and international Publications Chairperson, National Guideline of Psoriasis.
Partner image

Le psoriasis du cuir chevelu comme indicateur du rhumatisme psoriasique / Scalp psoriasis as an indicator of psoriatic arthritis

Nino Lortkipanidze, MD, PhD (graduated from Tbilisi Medical University, Georgia in 1996), Doctor (PhD) in Medicine (2006). Full Professor at D.Tvildiani Medical University (since 2022). Head of Department of Dermatology at MediClubGeorgia (since 2022). Head of Residency program in Dermatology and Venereology at Tbilisi Medical Academy (since 2018). President of Georgian Hair Research (since 2013). President of Eastern Europe and Asia Hair Research Society (since 2019) Author of over 50 scientific journal articles, co-author of the book “Psychotrichology”
Partner image

Améliorer l’observance des traitements contre le psoriasis / Improving compliance with psoriasis treatments

Steven R. Feldman MD, PhD,

Partner image

Traiter le psoriasis dans des populations particulières : quelles sont les preuves / Treating Psoriasis in Special Populations: What’s the evidence

Giovanni Damiani MD, PhD

Partner image

Psoriasis et comorbidités : une approche multidisciplinaire / Psoriasis and comorbidities: a multidisciplinary approach

Dr. Maria-Angeliki GKINI is a Consultant Dermatologist at 401 General Army Hospital in Athens, Greece, and a Locum Consultant Dermatologist at Barts Health NHS Trust in London. With expertise in psoriasis and inflammatory skin diseases, she has contributed to numerous research studies, spoken at international conferences, and received awards from prestigious institutions, including the European Academy of Dermatology and Venereology. Dr. Gkini’s interests also extend to artificial intelligence in dermatology and multidisciplinary approaches to skin conditions.
Partner image

DISCUSSIONS (session 3)

Steven R. Feldman MD, PhD,

Session 4 : Pigmentation diagnostics and therapeutics / Diagnostic et thérapeutique de la pigmentation

Prof. Bolognia Jean ; Prof. Sarkar Rashmi

Partner image

Managing Hyperpigmentation : Treatment Approaches for Asian Skin

Tatyana Vinnik

Partner image

Salt & Pepper dyspigmentation: diagnostic and severity marker of Systemic Sclerosis in patients of African descent. Case presentations and discussion

Jeannette Aryee-Boi

Partner image

Vitiligo : Diagnosis, Treatment & Care

Maimuna Stores MD

Partner image

Oral tranexamic acid in melasma

Professor of dermatology Department of Dermatology, D.Y.Patil University & School of Medicine Navi Mumbai India 150 publications 7 books, 20 chapters President IADVL 2020 President skin allergy society India Editor in chief Indian journal of skin allergy
Partner image

Disorders of hypopigmentation : A practical Approach

Professor Jean Bolognia MD is a distinguished dermatologist and a renowned figure in the field of dermatology. As a professor of dermatology at Yale University School of Medicine, she has made significant contributions to the advancement of dermatological knowledge and patient care. Throughout her illustrious career, Jean has held various leadership roles, including president of prestigious organizations like the Medical Dermatology Society, Women’s Dermatologic Society, and the American Dermatological Association. Her expertise is widely recognized on an international level, as demonstrated by her involvement in organizations such as the Society of Investigative Dermatology, the American Board of Dermatology, and the International Society of Dermatology. Jean’s commitment to the field has led her to serve on the Board of Directors of the American Academy of Dermatology and the International League of Dermatological Societies (ILDS), where she notably held the position of Secretary General. Jean Bolognia’s impact extends beyond her clinical and academic achievements. She is an accomplished editor, having worked on authoritative publications like the Dermatology Handbook (now in its fourth edition) and Dermatology Essentials (second edition). Through her extensive contributions to the field, Jean continues to inspire and educate dermatologists worldwide, leaving a lasting legacy in the world of dermatology.
Partner image

Update on topical and systemic therapies on melasma including tranexamic acid

Dr Rashmi Sarkar MD,FAMS,IFAAD, Director Professor Department of Dermatology LHMC and associated KSCH and SSK Hospital New Delhi Mob: 00919818244340 President IADVL 2022 President,IADVL Delhi State Branch(2018) Founder Chair ,Pigmentary Disorders Society(PDS) Past Secretary General IADVL(2014-15) Board of Directors, International Society of Dermatology(ISD) Chair ,International Mentorship Committee,ISD, International Representative,Board of Directors, Womens’ Dermatologic Society(WDS)(2011-13,2017-18), Member,International Sections Committee,WDS Chair,International and National Committee,Skin of Colors Society(SOCS), Chair,Womens’Committee,International Federation of Pigment Cell Societies(IFPCS) Founding President,Joint WDS-Indian WDS(WDS-IWDS) Former Board of Directors,Skin of Colors Society(SOCS) (2013-16) Editor-in-Chief ,Pigment International(PI)(2017-21) Associate Editor,Journal of Cutaneous and Aesthetic Surgery(JCAS)(2011-14) Subsection Editor,International Journal of Women’s Dermatology(IJWD) Associate Editor,Journal of Cosmetic Dermatology(JCD) Editorial Board,International Journal of Dermatology(IJD)(2014-17) Editorial Board,Journal of Cutaneous and Aesthetic Dermatology(JCAD) Editorial Board,Indian Journal of Dermatology(IJD) Section Editor,Indian Journal of Dermatology,Venereology and Leprology(IJDVL) Editorial Board,Indian Journal of Pediatric Dermatology(IJPD)
Partner image

DISCUSSIONS (session 4)

Professor Jean Bolognia MD is a distinguished dermatologist and a renowned figure in the field of dermatology. As a professor of dermatology at Yale University School of Medicine, she has made significant contributions to the advancement of dermatological knowledge and patient care. Throughout her illustrious career, Jean has held various leadership roles, including president of prestigious organizations like the Medical Dermatology Society, Women’s Dermatologic Society, and the American Dermatological Association. Her expertise is widely recognized on an international level, as demonstrated by her involvement in organizations such as the Society of Investigative Dermatology, the American Board of Dermatology, and the International Society of Dermatology. Jean’s commitment to the field has led her to serve on the Board of Directors of the American Academy of Dermatology and the International League of Dermatological Societies (ILDS), where she notably held the position of Secretary General. Jean Bolognia’s impact extends beyond her clinical and academic achievements. She is an accomplished editor, having worked on authoritative publications like the Dermatology Handbook (now in its fourth edition) and Dermatology Essentials (second edition). Through her extensive contributions to the field, Jean continues to inspire and educate dermatologists worldwide, leaving a lasting legacy in the world of dermatology.

Might interest you

Cutaneous Medicine: Multidisciplinary Approaches in Dermatology
PsychodermatologyDermoscopyNeglected Tropical Disease

Cutaneous Medicine: Multidisciplinary Approaches in Dermatology

Chair: Prof. Fahafahantsoa Rapelanoro Rabenja,

This course explores the intersection of dermatology with other medical specialties, emphasizing a collaborative approach to diagnosing and managing complex skin disorders. It covers a wide range of topics, including dermatopathology, rheumatology, oncology, and infectious diseases, highlighting how systemic conditions manifest cutaneously. With contributions from experts in various fields, the text provides comprehensive insights into multidisciplinary care, advanced diagnostic techniques, and innovative treatments. Ideal for dermatologists, internists, and specialists, it bridges gaps between disciplines to improve patient outcomes in cutaneous medicine.

Pigmentation
Pigmentation

Pigmentation

Chair: Dr Seemal Desai, MD, FAAD

Hyperpigmentation is excess skin color from melanin. Understand melanin synthesis mechanisms and main causes.

Neglected Tropical Skin Diseases
Neglected Tropical Disease

Neglected Tropical Skin Diseases

Chair: Dr. Prajwal Pudasaini, MD

Neglected tropical skin diseases affect poor populations in tropical areas. They include leprosy, mycetoma, and cutaneous leishmaniasis, causing disability and stigma. They receive little attention and resources, leading to poor diagnosis and treatment. Increased awareness and improved healthcare access are needed to help affected communities.

Acne Treatment in China
TCM Chinese Medicine

Acne Treatment in China

Chair: Prof. Haiping Zhang, PhD

Acne treatment in China combines traditional methods with modern practices.

Cyspera Medical Education
Pigmentation

Cyspera Medical Education

Chair: Global Dermatology,

Cyspera® is a topical pigment-correcting treatment formulated with cysteamine, a naturally occurring compound that reduces the appearance of persistent hyperpigmentation, including melasma, post-inflammatory hyperpigmentation, and lentigines. It is known for being non-hydroquinone, suitable for long-term use, and effective on all skin types.

Topographic Dermoscopy

Topographic Dermoscopy

Chair: Prof. Awatef Kelati, MD

Topographic dermoscopy refers to the region-specific application of dermoscopic examination, emphasizing the unique morphological patterns found across different anatomical sites. On facial skin, the dermoscopic assessment requires recognizing patterns influenced by the high density of pilosebaceous units and sun-induced changes, often presenting pseudonetworks and annular-granular structures. The ear, with its thin skin and sebaceous gland concentration, reveals specific vascular and follicular clues important in distinguishing benign from malignant lesions.

On the chest and back, where the skin is thicker and sun exposure varies, dermoscopy must account for irregular pigment distribution and architectural disorder, especially in large nevi or early melanomas. Limb lesions may show distinctive features due to mechanical friction, hair density, and vascular variations, demanding precise interpretation to identify atypical nevi or skin cancers.

Palmar and plantar dermoscopy highlights the parallel ridge pattern critical for melanoma diagnosis, contrasting with benign acral patterns like the parallel furrow or lattice-like structures. Scalp and hair disorders benefit from trichoscopy, where dermoscopic evaluation reveals specific signs such as yellow dots, broken hairs, or black dots, aiding in the diagnosis of alopecia areata, androgenetic alopecia, or tinea capitis.

In nail disorders, onychoscopy enables visualization of melanonychia, hemorrhages, and nail matrix changes, crucial for distinguishing subungual melanoma from benign causes like trauma or fungal infection. Mucosal dermoscopy, though technically challenging, provides diagnostic clues in pigmented lesions of the lips, genitalia, or oral mucosa, requiring adaptation to moist, non-keratinized surfaces.

Finally, ultraviolet dermoscopy reveals a unique application: scabies mites fluorescing bright green under UV light, enhancing detection when traditional visualization fails. Topographic dermoscopy thus demands both anatomical knowledge and technical adaptation to maximize diagnostic accuracy across diverse body sites.

ACNE
Acne

ACNE

Chair: Dr. Jerry Tan, MD

The ACNE | Education Series, led by Dr. Jerry Tan, is a comprehensive global medical education initiative designed to enhance the understanding and skills of dermatologists and healthcare practitioners regarding acne. Participants will gain insights from leading international experts on the latest advancements in acne research, innovative treatment options, and patient-centered care approaches. The event features interactive discussions, live Q&A sessions, and evidence-based strategies, all at no cost. The esteemed faculty includes specialists from the USA, Italy, France, the UK, Singapore, Greece, Australia, Canada, and Germany. This is a valuable opportunity to improve clinical competencies and stay updated on current acne management practices.

Attendees will acquire up-to-date knowledge on acne pathophysiology, new therapeutic options, and patient-oriented management strategies to optimize clinical outcomes in acne treatment. The session will also provide practical insights through expert-led discussions and evidence-based approaches.

Psychodermatology
Psychodermatology

Psychodermatology

Chair: Prof Mohammad Jafferany, MD

This specialized course explores the vital intersection between dermatology and mental health, equipping clinicians with the knowledge and tools to manage psychodermatological conditions effectively. Through a blend of theoretical knowledge and practical application, participants will learn to diagnose and treat dermatological delusional disorders, identify psychiatric comorbidities in skin disease patients, and implement mental health strategies for chronic dermatoses. The curriculum also examines psychological factors in cosmetic dermatology and provides cutting-edge screening techniques for body dysmorphic disorder, including modern digital manifestations like Zoom dysmorphia. Adopting a patient-centered approach, the course emphasizes multidisciplinary management of conditions where psychological and dermatological factors interact. Participants will gain expertise in recognizing psychiatric components of skin diseases, addressing the emotional

burden of chronic conditions, and applying ethical principles in cosmetic practice. The training combines expert instruction with case-based learning to bridge theory and clinical practice. Designed for dermatologists, psychiatrists, psychologists, and primary care providers, this program enhances clinicians' ability to deliver holistic care that addresses both the visible and invisible aspects of skin disorders. Upon completion, practitioners will be better prepared to manage complex psychodermatological cases while improving patient outcomes through integrated mind-skin healthcare.


Tropical Dermatology and Neglected Tropical Dermatoses
Neglected Tropical Disease

Tropical Dermatology and Neglected Tropical Dermatoses

Chair: Prof. Fahafahantsoa Rapelanoro Rabenja,

Dermatological diseases, particularly neglected tropical diseases (NTDs) with skin manifestations like deep mycosis (chromoblastomycosis, sporotrichosis, mycetoma), scabies, leprosy, lymphatic filariasis, and cutaneous leishmaniasis, pose major challenges for healthcare systems in resource-limited regions of Africa, Asia, and Latin America. These conditions severely affect vulnerable populations, suffering from frequent underdiagnosis and inadequate treatment that exacerbates suffering. Diseases such as atopic dermatitis are also under consideration for inclusion as skin NTDs through collaborative efforts involving ISAD, ASDV, and WHO. Furthermore, albinism, highly prevalent in sub-Saharan Africa, presents significant social challenges including stigmatization and occult beliefs. Despite these complex difficulties, the field is undergoing a historic transformation driven by science and technology, particularly artificial intelligence (AI), which offers tangible tools for improving diagnosis, treatment, and prevention. The participation of global experts facilitates vital knowledge exchange, exploration of innovative solutions, and helps address critical shortages of human and material resources in remote areas.


Learning Objective:

Understand the complex challenges posed by dermatological diseases, especially skin NTDs and conditions like albinism, in resource-limited settings, and recognize the critical role of global collaboration, technological innovation (particularly AI), and expert knowledge exchange in developing solutions to improve diagnosis, treatment, prevention, and resource allocation.

Dermoscopy
Dermoscopy

Dermoscopy

Chair: Prof Awatef Kelati, MD

This comprehensive dermoscopy course provides dermatologists and healthcare professionals with essential skills in skin lesion evaluation, covering fundamental principles through advanced diagnostic applications across five key areas: global dermoscopy practices, pigmented lesion analysis (including differentiation of benign and malignant patterns), specialized techniques for skin of color, skin cancer detection (melanoma and non-melanoma), and general dermatological conditions (inflammatory, infectious, and hair/nail disorders). Participants will develop proficiency in recognizing diagnostic patterns, adapting techniques for diverse skin types, and applying dermoscopic algorithms, ultimately enhancing their clinical accuracy through a combination of theoretical knowledge and practical case-based learning. The course emphasizes real-world application, addressing both common and challenging scenarios in dermatological practice.